BUB
TMO icon

BBVA USA Bancshares’s Thermo Fisher Scientific TMO Stock Holding History

BBVA USA Bancshares’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$8.31M Sell
18,200
-1,164
-6% -$556K 0.4% 67
2020
Q4 		$9.02M Sell
19,364
-4,773
-20% -$2.24M 0.46% 46
2020
Q3 		$10.3M Sell
24,137
-2,742
-10% -$1.13M 0.59% 37
2020
Q2 		$9.74M Sell
26,879
-1,967
-7% -$659K 0.58% 35
2020
Q1 		$8.18M Buy
28,846
+1,360
+5% +$429K 0.59% 39
2019
Q4 		$8.93M Sell
27,486
-1,713
-6% -$519K 0.51% 47
2019
Q3 		$8.51M Buy
29,199
+174
+0.6% +$49.8K 0.55% 45
2019
Q2 		$8.52M Sell
29,025
-345
-1% -$95K 0.51% 43
2019
Q1 		$8.04M Sell
29,370
-2,114
-7% -$526K 0.51% 49
2018
Q4 		$7.05M Sell
31,484
-2,165
-6% -$508K 0.5% 49
2018
Q3 		$8.21M Buy
33,649
+70
+0.2% +$16.1K 0.49% 48
2018
Q2 		$6.96M Buy
33,579
+2,021
+6% +$429K 0.44% 55
2018
Q1 		$6.52M Buy
31,558
+1,887
+6% +$396K 0.42% 58
2017
Q4 		$5.63M Buy
29,671
+2,746
+10% +$526K 0.36% 68
2017
Q3 		$5.09M Buy
26,925
+1,796
+7% +$325K 0.33% 79
2017
Q2 		$4.38M Sell
25,129
-41
-0.2% -$6.89K 0.29% 87
2017
Q1 		$3.87M Buy
25,170
+1,222
+5% +$187K 0.26% 96
2016
Q4 		$3.38M Buy
23,948
+1,315
+6% +$194K 0.24% 104
2016
Q3 		$3.6M Buy
22,633
+874
+4% +$135K 0.26% 96
2016
Q2 		$3.21M Buy
21,759
+3,655
+20% +$539K 0.24% 102
2016
Q1 		$2.56M Buy
18,104
+2,190
+14% +$293K 0.19% 118
2015
Q4 		$2.26M Buy
15,914
+15
+0.1% +$2K 0.17% 132
2015
Q3 		$1.94M Sell
15,899
-398
-2% -$51.9K 0.15% 134
2015
Q2 		$2.12M Sell
16,297
-1,113
-6% -$145K 0.12% 158
2015
Q1 		$2.34M Sell
17,410
-2,260
-11% -$291K 0.1% 182
2014
Q4 		$2.46M Sell
19,670
-3,292
-14% -$400K 0.11% 175
2014
Q3 		$2.79M Sell
22,962
-10,511
-31% -$1.28M 0.12% 171
2014
Q2 		$3.95M Buy
33,473
+421
+1% +$49.5K 0.17% 149
2014
Q1 		$3.97M Sell
33,052
-469
-1% -$55.8K 0.18% 150
2013
Q4 		$3.73M Sell
33,521
-140
-0.4% -$13.9K 0.16% 153
2013
Q3 		$3.1M Sell
33,661
-1,101
-3% -$99.6K 0.15% 161
2013
Q2 		$2.94M Buy
+34,762
New +$2.89M 0.15% 162

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BBVA USA Bancshares's TMO Position: Q1 2021 in Review

BBVA USA Bancshares reduced its Thermo Fisher Scientific (TMO) stake by 6% in Q1 2021, selling an estimated $556K and leaving 18,200 shares worth $8.31M. The position accounts for 0.4% of the portfolio, ranked #67.

BBVA USA Bancshares first reported a position in TMO in Q2 2013 and has held it in 32 quarters since. The position peaked at $10.3M in Q3 2020. 2,042 funds tracked by Wall St. Rank hold TMO as of Q1 2021.

  • BBVA USA Bancshares held 18,200 shares of Thermo Fisher Scientific worth $8.31M as of Q1 2021.
  • BBVA USA Bancshares sold 1,164 Thermo Fisher Scientific shares in Q1 2021, an estimated $556K.
  • Thermo Fisher Scientific made up 0.4% of BBVA USA Bancshares's portfolio in Q1 2021, its #67 holding.
  • BBVA USA Bancshares first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 32 quarters since.
  • BBVA USA Bancshares's Thermo Fisher Scientific position peaked at $10.3M in Q3 2020.
  • 2,042 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2021.

Based on BBVA USA Bancshares's 13F filing for Q1 2021, filed 23 Apr 2021.